Add Company
Join Now

AgoMab Revenue and Competitors

License our Company Data API

Ghent,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • AgoMab's estimated annual revenue is currently $8.4M per year.(i)
  • AgoMab's estimated revenue per employee is $155,000

Employee Data

  • AgoMab has 54 Employees.(i)
  • AgoMab grew their employee count by 10% last year.

AgoMab's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
General CounselReveal Email/Phone
3
Head Operations R&DReveal Email/Phone
4
Chief Financial OfficerReveal Email/Phone
5
Chief Medical OfficerReveal Email/Phone
6
Chief Scientific OfficerReveal Email/Phone
7
Project Manager Early DevelopmentReveal Email/Phone
8
Scienziato associatoReveal Email/Phone
9
Scienziato associatoReveal Email/Phone
10
Research And Development ChemistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is AgoMab?

AgomAb is developing molecular therapies for the regeneration of damaged tissues. Our unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.

keywords:N/A

N/A

Total Funding

54

Number of Employees

$8.4M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7M54-8%N/A
#2
N/A5743%N/A
#3
$13.1M619%N/A
#4
$11.2M629%N/A
#5
$3.5M66-4%N/A